Cvs Fast Acting Baby Teething

Description

The drug is formulated as a tablet containing the active ingredient insert active ingredient name here. The tablet exhibits insert physical characteristics, e.g., color, shape, size. Inactive ingredients include list of inactive ingredients.

Uses and Indications

This drug is indicated for the temporary relief of sore gums associated with teething in infants and children aged 4 months or older.

Dosage and Administration

Healthcare professionals should ensure that hands are thoroughly cleaned before application. The tip of the tube should be cut open at the designated score line. A small, pea-sized amount of CVS Baby Teething Gel should be applied to the affected area using either a fingertip or a cotton swab. The gel may be applied up to four times a day, or as directed by a dentist or doctor.

For infants under 4 months of age, it is essential to consult a dentist or doctor prior to use.

Contraindications

There are no contraindications associated with the use of this product. It is not classified as a controlled substance, and there are no known risks of abuse, misuse, or dependence. Additionally, there are no specific instructions indicating that the product should not be taken or used under any circumstances.

Warnings and Precautions

The use of this product is contraindicated in infants with a known allergy to local anesthetics, including but not limited to butacaine, benzocaine, procaine, or other "caine" anesthetics. Healthcare professionals should ensure that patients do not exceed the recommended dosage or duration of use, which is limited to a maximum of 7 days unless otherwise directed by a dentist or physician.

It is important to note that fever and nasal congestion are not typical symptoms of teething and may suggest an underlying infection. Should these symptoms persist, it is advised to consult a dentist or physician for further evaluation.

Patients should be instructed to discontinue use and seek medical advice if sore gum symptoms do not improve within 7 days. Additionally, if irritation, pain, or redness persists, or if any rash, swelling, or fever develops, immediate medical consultation is warranted.

In the event of an allergic reaction or suspected overdose, patients must seek emergency medical assistance or contact a Poison Control Center without delay.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. An allergy alert is in place, advising against the use of this product in individuals with a history of allergy to local anesthetics, including butacaine, benzocaine, procaine, or other "caine" anesthetics.

It is crucial that patients do not exceed the recommended dosage or use the product for more than 7 days unless directed by a dentist or doctor. During the use of this product, patients should be vigilant for symptoms such as fever and nasal congestion, which are not typical signs of teething and may indicate an underlying infection. If these symptoms persist, it is recommended that patients contact their dentist or doctor for further evaluation.

Patients are advised to discontinue use and consult a dentist or doctor if sore gum symptoms do not improve within 7 days. Additionally, if irritation, pain, or redness persists, or if a rash, swelling, or fever develops, medical consultation is warranted. In the event of an allergic reaction or overdose, immediate medical attention should be sought, or patients should contact a Poison Control Center.

Drug Interactions

The use of this product is contraindicated in patients with a known allergy to local anesthetics, specifically those with a history of hypersensitivity to butacaine, benzocaine, procaine, or other anesthetics belonging to the "caine" class.

Healthcare professionals should ensure that patients are screened for any previous allergic reactions to these agents prior to administration. In cases where a history of such allergies is present, alternative therapeutic options should be considered to avoid potential adverse reactions.

Packaging & NDC

Below are the non-prescription pack sizes of Cvs Fast Acting Baby Teething (benzocaine). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 4 months and older may use this product for the temporary relief of sore gums due to teething. For infants under 4 months of age, consultation with a dentist or doctor is advised prior to use.

Healthcare professionals should be aware of an allergy alert: this product should not be used in patients with a history of allergy to local anesthetics, including butacaine, benzocaine, procaine, or other "caine" anesthetics.

Dosing should not exceed the recommended amount or duration of 7 days unless directed by a dentist or doctor. It is important to note that fever and nasal congestion are not typical symptoms of teething and may suggest an underlying infection; if these symptoms persist, a healthcare provider should be contacted.

If symptoms of sore gums do not improve within 7 days, or if irritation, pain, or redness persists, or if a rash, swelling, or fever develops, the patient should discontinue use and seek advice from a dentist or doctor.

Geriatric Use

Elderly patients have not been specifically studied in relation to the use of this product, and no information regarding geriatric use is provided in the prescribing information. The product is primarily intended for infants and children aged 4 months and older.

Given the absence of data on safety, efficacy, or dosage adjustments for elderly patients, healthcare providers should exercise caution when considering this product for geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or unexpected responses, as individual health status and comorbidities may influence treatment outcomes.

Pregnancy

There are no specific warnings, precautions, or dosage modifications regarding the use of CVS Fast Acting Baby Teething - benzocaine gel in pregnant patients. The prescribing information does not indicate whether the product is contraindicated during pregnancy or if there are any associated risks to the fetus. Additionally, no safety concerns related to the use of this product during pregnancy have been provided. Healthcare professionals should consider the lack of data when advising women of childbearing potential regarding the use of this product.

Lactation

Lactating mothers should consult a healthcare professional before using this product. There is a potential for excretion in breast milk, and the effects on a nursing infant are not well studied; therefore, caution is advised.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdose or an allergic reaction, it is imperative to seek immediate medical attention. Healthcare professionals are advised to contact a Poison Control Center without delay to ensure appropriate management of the situation.

Symptoms of an overdose may vary depending on the specific substance involved; however, vigilance is essential in monitoring for any adverse reactions. Prompt recognition of symptoms can facilitate timely intervention and improve patient outcomes.

Management of an overdose should be guided by the severity of symptoms and the specific circumstances surrounding the incident. Healthcare providers should follow established protocols for overdose management, which may include supportive care and symptomatic treatment as necessary.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

Postmarketing experience has revealed that benzocaine products, including CVS Fast Acting Baby Teething Gel, have been associated with a rare but serious condition known as methemoglobinemia. This condition can occur following the use of benzocaine products. Symptoms of methemoglobinemia may include cyanosis (a bluish discoloration of the skin), shortness of breath, fatigue, and increased heart rate.

The risk of developing methemoglobinemia is notably higher in infants and young children, particularly those under 2 years of age. It is essential for healthcare professionals and caregivers to be vigilant regarding the signs and symptoms of methemoglobinemia and to seek immediate medical attention if these symptoms occur.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important for patients to understand the potential risks associated with the medication, including the possibility of allergic reactions or overdose. In such cases, patients should be instructed to seek medical attention immediately or contact a Poison Control Center for guidance. This information is crucial for ensuring patient safety and promoting responsible use of the medication.

Storage and Handling

The product is supplied in a tube format. It is essential to ensure that the tube tip remains uncut prior to opening, as using the product with a cut tube tip is not recommended.

For optimal storage and handling, the product should be kept in a controlled environment, away from extreme temperatures and direct sunlight. Specific temperature ranges and container requirements are not provided; however, general best practices for storage should be followed to maintain product integrity. Special handling needs include ensuring that the tube is intact and sealed until ready for use.

Additional Clinical Information

The medication is administered orally and should be applied to the affected area up to four times a day, or as directed by a dentist or doctor. Clinicians should advise patients to keep the product out of reach of children and to seek immediate medical attention or contact a Poison Control Center in the event of an allergic reaction or overdose.

Patients should be cautioned against use if there is a known allergy to local anesthetics, including butacaine, benzocaine, procaine, or other "caine" anesthetics. Symptoms such as fever and nasal congestion are not typical of teething and may suggest an underlying infection; persistent symptoms should prompt consultation with a healthcare provider. Additionally, patients should discontinue use and consult a dentist or doctor if symptoms of sore gums do not improve within 7 days, or if irritation, pain, redness, rash, swelling, or fever occurs. For infants under 4 months of age, consultation with a dentist or doctor is recommended prior to use.

Drug Information (PDF)

This file contains official product information for Cvs Fast Acting Baby Teething, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)